APA aipamena

Moharram, S. A., Shah, K., Khanum, F., Rönnstrand, L., & Kazi, J. U. (2019). The ALK inhibitor AZD3463 effectively inhibits growth of sorafenib-resistant acute myeloid leukemia. Blood Cancer J.

Chicago Style aipamena

Moharram, Sausan A., Kinjal Shah, Fatima Khanum, Lars Rönnstrand, and Julhash U. Kazi. "The ALK Inhibitor AZD3463 Effectively Inhibits Growth of Sorafenib-resistant Acute Myeloid Leukemia." Blood Cancer J 2019.

MLA aipamena

Moharram, Sausan A., et al. "The ALK Inhibitor AZD3463 Effectively Inhibits Growth of Sorafenib-resistant Acute Myeloid Leukemia." Blood Cancer J 2019.